Literature DB >> 16087342

Influence of esterification and modification of A-ring in a group of lupane acids on their cytotoxicity.

Milan Urban1, Jan Sarek, Iva Tislerova, Petr Dzubak, Marian Hajduch.   

Abstract

The aim of this work was to find an optimal ester group for preparation of lupane derivatives connecting high cytotoxicity with good chemical and pharmacological properties. Activities of methyl-, pivaloyloxymethyl- (Pom-), and acetoxymethyl- (Acm-) esters were compared with the activity of free acids. Although the methyl- and Pom-esters were generally less active than free acids, some Acm-esters had cytotoxicity similar to or even better than the starting compounds. Cytotoxic activity was measured in five cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087342     DOI: 10.1016/j.bmc.2005.07.011

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice.

Authors:  Matheus Santos de Sá; José Fernando Oliveira Costa; Antoniana Ursine Krettli; Mariano Gustavo Zalis; Gabriela Lemos de Azevedo Maia; Ivana Maria Fechine Sette; Celso de Amorim Câmara; José Maria Barbosa Filho; Ana Maria Giulietti-Harley; Ricardo Ribeiro Dos Santos; Milena Botelho Pereira Soares
Journal:  Parasitol Res       Date:  2009-04-15       Impact factor: 2.289

2.  Esters of valerenic acid as potential prodrugs.

Authors:  Juliane Hintersteiner; Maximilian Haider; Denise Luger; Christoph Schwarzer; Gottfried Reznicek; Walter Jäger; Sophia Khom; Marko D Mihovilovic; Steffen Hering
Journal:  Eur J Pharmacol       Date:  2014-03-27       Impact factor: 5.195

3.  Cytotoxic conjugates of betulinic acid and substituted triazoles prepared by Huisgen Cycloaddition from 30-azidoderivatives.

Authors:  Veronika Sidova; Pavel Zoufaly; Jan Pokorny; Petr Dzubak; Marian Hajduch; Igor Popa; Milan Urban
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.